Adobe Document Cloud*, including Adobe Acrobat DC, Adobe Reader DC and Adobe Sign, is now SAFE-BioPharma® certified. Adobe Document Cloud solutions help Life Sciences companies protect critical data and documents, while complying with signature laws and regulations around the globe. With more than seven billion mobile devices in the world and cyber-threats at an all-time high, demand has surged for simple, more secure ways to provide options for trusted electronic signatures. The SAFE-BioPharma® certification helps Life Sciences companies provide global high-assurance identity trust for cyber-transactions that rely on service providers.
Working with the world’s most trusted digital IDs today, Adobe Sign enables desktop signing with over 200 providers from the European Union Trust List (EUTL) and Adobe Approved Trust List (AATL). Adobe Sign is compliant with SOC2-Type 2, ISO-27001, PCI-DSS, and HIPAA requirements and can be configured to comply with FERPA, GLBA, and FDA 21 CFR Part 11. Now, with SAFE-BioPharma® certification, Life Sciences and Pharmaceutical companies can use Adobe Document Cloud for patient consent forms, field service reports, lot traceability, supplier contracts and more, in any browser or on any mobile device with added confidence.
Over the past several years, Adobe has made significant investments across the company to pursue compliance with significant certifications, regulations and standards. These accomplishments for Adobe’s cloud services and solutions, such as Adobe Sign, allow us to provide our customers with assurance that their data and applications are more secure.
Sr. Director of Risk Advisory and Assurance